Master
Content
- Proteogenomic Markers of Chemotherapy Resistance and Response in Triple-Negative Breast Cancer
- The importance of a biomarker-directed approach in triple-negative breast cancer (video)
- LIG1 deletion predicts chemotherapy resistance in triple-negative breast cancer (video)
- Treatments for HR+ postmenopausal breast cancer (video)
- OCCPR Webinar: Translational Discovery and Validation Using Multi-omics Data from ER+ Breast Tumors (video)
- Meenakshi Anurag on Breast Cancer: New Data on Combining Anastrozole and Fulvestrant
